BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 29021405)

  • 1. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
    Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A; de Oliveira CF; Lopes C; Cunha MJ;
    Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.
    Pérez-Castro S; Lorenzo-Mahía Y; Iñarrea Fernández A; Lamas-González MJ; Sarán-Díez MT; Rubio-Alarcón J; Reboredo-Reboredo MC; Mosteiro-Lobato S; López-Miragaya I; Torres-Piñón J; Melón-García S
    Enferm Infecc Microbiol Clin; 2014 Oct; 32(8):479-85. PubMed ID: 24274937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women.
    Suthipintawong C; Siriaunkgul S; Tungsinmunkong K; Pientong C; Ekalaksananan T; Karalak A; Kleebkaow P; Vinyuvat S; Triratanachat S; Khunamornpong S; Chongsuwanich T
    Asian Pac J Cancer Prev; 2011; 12(4):853-6. PubMed ID: 21790214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
    Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
    J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
    Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
    Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    Zhang L; Bi Q; Deng H; Xu J; Chen J; Zhang M; Mu X
    BMC Infect Dis; 2017 Jan; 17(1):107. PubMed ID: 28143439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China.
    Chan PK; Cheung TH; Li WH; Yu MY; Chan MY; Yim SF; Ho WC; Yeung AC; Ho KM; Ng HK
    Int J Cancer; 2012 Aug; 131(3):692-705. PubMed ID: 21976212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study.
    Prétet JL; Jacquard AC; Saunier M; Clavel C; Dachez R; Gondry J; Pradat P; Soubeyrand B; Leocmach Y; Mougin C; Riethmuller D;
    Gynecol Oncol; 2008 Aug; 110(2):179-84. PubMed ID: 18514800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
    Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.
    Anderson LA; O'Rorke MA; Wilson R; Jamison J; Gavin AT;
    J Med Virol; 2016 Jul; 88(7):1262-70. PubMed ID: 26680281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.
    Li J; Gao JJ; Li N; Wang YW
    Arch Virol; 2021 Mar; 166(3):853-862. PubMed ID: 33486629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
    Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
    Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
    Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
    Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
    Zhang J; Cheng K; Wang Z
    Arch Gynecol Obstet; 2020 Dec; 302(6):1329-1337. PubMed ID: 32914222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.